• Dagmar M Ouweneel, Erlend Eriksen, Krischan D Sjauw, Ivo M van Dongen, Alexander Hirsch, PackerErik J SEJDepartment of Heart Disease, Haukeland University Hospital, Bergen, Norway., M Marije Vis, Joanna J Wykrzykowska, Karel T Koch, Jan Baan, Robbert J de Winter, Jan J Piek, Wim K Lagrand, Bas A J M de Mol, Jan G P Tijssen, and José P S Henriques.
• AMC Heart Center, Academic Medical Center-University of Amsterdam, Amsterdam, the Netherlands.
• J. Am. Coll. Cardiol. 2017 Jan 24; 69 (3): 278-287.

BackgroundDespite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions.ObjectivesThe aim of this study was to determine whether a new percutaneous mechanical circulatory support (pMCS) device (Impella CP, Abiomed, Danvers, Massachusetts) decreases 30-day mortality when compared with an intra-aortic balloon pump (IABP) in patients with severe shock complicating AMI.MethodsIn a randomized, prospective, open-label, multicenter trial, 48 patients with severe CS complicating AMI were assigned to pMCS (n = 24) or IABP (n = 24). Severe CS was defined as systolic blood pressure <90 mm Hg or the need for inotropic or vasoactive medication and the requirement for mechanical ventilation. The primary endpoint was 30-day all-cause mortality.ResultsAt 30 days, mortality in patients treated with either IABP or pMCS was similar (50% and 46%, respectively; hazard ratio with pMCS: 0.96; 95% confidence interval: 0.42 to 2.18; p = 0.92). At 6 months, mortality rates for both pMCS and IABP were 50% (hazard ratio: 1.04; 95% confidence interval: 0.47 to 2.32; p = 0.923).ConclusionsIn this explorative randomized controlled trial involving mechanically ventilated patients with CS after AMI, routine treatment with pMCS was not associated with reduced 30-day mortality compared with IABP. (IMPRESS in Severe Shock; NTR3450).Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

19 keywords...

hide…